A phase 1/2 clinical trial examining the CRISPR-engineered allogeneic chimeric antigen receptor (CAR)-T candidate AVC-203 (QUADvance) has been approved by the FDA and the European Medicines Agency ...
The CBSE Class 10 and Class 12 board examinations will begin on February 17. The Class 10 exams will end on March 10, while Class 12 exams will conclude on April 9. Ahead of the board exams, CBSE ...
Discover Vor BiopharmaVor Biopharma Inc.'s potential with telitacicept amid funding challenges and market risks. Click for ...
A quick revision guide covering key concepts, biomolecules, cell organelles, and essential NEET-style MCQs to boost exam ...
XmAb819 demonstrated a manageable safety profile with primarily grade 1 or 2 cytokine release syndrome and no neurotoxicity in ccRCC patients. The trial involved 69 patients, with a 25% objective ...
Two years after this, Sakaguchi was able to link these discoveries. He proved that the Foxp3 gene governs the development of ...
Where the BYDs are for everyone, a Yangwang is a cut above—luxury, performance, and a lil bit of "better than you." It's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback